Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- US stock futures rise as oil pullback amplifies Fed rate-hike boost
- Oil prices extend losses as supply disruption fears ease
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Iovanace Biotherapeutics (IOVA) Has Strong Cash Cushion Even as CEO Exit Adds to Uncertainties - Mizuho
May 19, 2021 12:42 PM EDTMizuho Securities analyst Mara Goldstein weighed in on Iovanace Biotherapeutics (NASDAQ: IOVA) after the company announced that Maria Fardis, Ph.D. will resign as President and CEO of the company following today's regulatory setback.
"The commercial potential for lifileucel remains but the question... More
Iovance Biotherapeutics (IOVA) Halted on LUDP
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
Iovance Biotherapeutics (IOVA) CEO Resigns
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) disclosed:
On May 18, 2021, Maria Fardis, Ph.D., the Chief Executive Officer (CEO) of Iovance Biotherapeutics, Inc. (the Company), notified the Company that she will be resigning as President, CEO and a director of the Company to pursue other opportunities. The... More
